The government finally comes into act as the complaints over the pricing of medical devices such as cardiac stents, implants. There has been a recommendation on the creation of the National Medical Devices Authority (NDMA), an autonomous body for price control by bringing it under the Essential Commodities Act said an official. Presently, the drug prices are notified through the Drug Prices Control Order. The government may also announce a separate policy for the price control of identified medical devices.

The NMDA may have an head ranked with additional/joint secretory and will include a secretory,  two medical practitioners, two medical device technologists or scientists and the secretary general of Quality Council of India (ex-officio).  In India, 70 to 80% of medical devices are imported while the domestic industry manufactures medical supplies and disposables. The complaints for over pricing has relatively increased over the last few months, as the medical devices is sold at a price of three to four times higher than the landing cost.

Regulated Medical devices include spinal needles, cochlear implants, annuloplasty rings, trachestomy tubes, syringes and needle, dental implants (dental market overview), surgical sealants, heart valves, cardiac stents, orthopedic implants, spinal implants, endotracheal tubes, and catheters, among others. Diagnostic equipment, several IVDs, medical equipment require special considerations.

The Times of India

Other News

Indian Govt Notifies New Norms to Regulate Medical Devices

On February 2, 2017 The Ministry of Health and Family Welfare has announced Medical Devices Rules, 2017 that separates regulatory norms for manufacturing medical devices from drugs. The rules will come into effect from January […]

Read More

Maharashtra FDA Asks Blood Banks to Submit License Renewal Applications

Maharashtra Food and Drug Administration (FDA) has directed all 306 blood banks in the state to submit applications of renewal of licenses by 31st December 2016 to carry out timely inspections and approvals. There are […]

Read More

Indian Syringe and Needle Market 2015-2020

Indian syringes and needles market is expected to grow at a CAGR of 15% by 2020. This growth is mainly because of India’s large pool of patients, increase in healthcare expenditure, increase in healthcare awareness […]

Read More

FSSAI Drafts Safety Regulations for Nutraceuticals & Food Supplements

The Ministry of Health’s Food Safety Standards Authority of India has come out with quality and safety standards to regulate the standards and quality of health supplements, nutraceuticals, food (special dietary care, medicinal purpose, functional […]

Read More

FSSAI Proposes New Rules for Health Supplement misabelling

On Monday, Indian food safety watchdog the Food Safety and Standards Authority of India (FSSAI) announced that health supplements cannot be sold as medicines at all and also fixed the permissible limits of various ingredients […]

Read More

More Than Half of Women Plan to Buy Natural Beauty Products

Now a new survey shows that, natural products continue to remain top of mind for many women when it comes to the personal care beauty products. The second annual Green Beauty Barometer survey questioned more […]

Read More

Korean Entrepreneurs to Venture into Indian Cosmetics Market

The United States remains the biggest market for Korean cosmetic products and nowadays Korean investors are venturing into Indian cosmetic market. The Korea Trade Investment Promotion Agency (KOTRA) launched at least 10 Korean cosmetics brands […]

Read More

Meet Us at The Medical Device Regulatory Summit in Mumbai

The first Medical Device Regulatory Summit in India is being held at Holiday Inn Mumbai International Airport on 29 November 2016. Morulaa HealthTech is pleased to partner at this event. Medical Device Regulatory Summit 2016, […]

Read More